chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: M
Vaccine: FLUN3, HEPA, SMALL, TYP
Symptoms: Convulsion, Coordination abnormal, Culture negative, Electroencephalogram abnormal, Encephalitis post immunisation
Clinical narrative: This serious case was received via a search of the scientific literature on 12 January 2009. A 40-year-old male serviceman received the following vaccinations on an unknown day in 2005 in preparation for active military duty: smallpox vaccine, typhoid vaccine, hepatitis A vaccine, (manufacturers not reported) and FLUMIST (MedImmune Vaccines). Lot numbers, and site of administration were not reported. The patient had received a primary smallpox vaccination in 1986, 19 years earlier, when he joined the military. He had no reported medical history. Five days post-vaccination, the patient developed photophobia. He was hospitalized eight days post-vaccination, and upon admission was noted to be confused and agitated. Physical examination showed a temperature of 38.2 degrees Celsius, increased upper extremity tone, low-frequency tremor, and a Glasgow coma score of 10. A rash was noted at the site of vaccination. Lumbar puncture revealed an opening pressure of 15 cm of water, a protein concentration of 122 mg/dL, and a WBC count of 294 cells/uL, with 76% lymphocytes and 24% neutrophils. An electroencephalogram revealed diffuse theta-frequency slowing without epileptiform discharges; brain MRI showed no significant abnormalities. The patient was initially treated with ACYCLOVIR, and then PHENYTOIN when he developed generalized seizures. A repeat lumbar puncture 11 days post-vaccination showed an opening pressure of 19 cm of water, a protein concentration of 95 mg/dL, and a WBC count of 137 cell/uL, with 89% lymphocytes, 1% neutrophils, and 10% monocytes. His status improved gradually, and he was discharged 16 days post-vaccination. At the time of discharge, he exhibited residual deficits in short-term memory, coordination, and balance. Serum and CSF samples sent to the Poxvirus Program at the CDC were negative for orthopox virus DNA, and IgM antibody was undetectable. Vaccinia-specific IgG antibody was detected in both serum and CSF. Results of extensive testing for infectious agents were negative. According to the authors, "the five-day lapse to onset of neurological symptoms after secondary smallpox vaccination and lack of evidence of direct CNS infection suggest an autoimmune response to vaccination". In conclusion, it was noted that "the patient in this report meets the surveillance case definition for probably PVE(postvaccinia encephalitis)."
Age: 40.0
Sex: M
Vaccine: FLUN3, HEPA, SMALL, TYP
Symptoms: Hypertonia, Injection site rash, Lumbar puncture abnormal, Nuclear magnetic resonance imaging brain normal, Photophobia
Clinical narrative: This serious case was received via a search of the scientific literature on 12 January 2009. A 40-year-old male serviceman received the following vaccinations on an unknown day in 2005 in preparation for active military duty: smallpox vaccine, typhoid vaccine, hepatitis A vaccine, (manufacturers not reported) and FLUMIST (MedImmune Vaccines). Lot numbers, and site of administration were not reported. The patient had received a primary smallpox vaccination in 1986, 19 years earlier, when he joined the military. He had no reported medical history. Five days post-vaccination, the patient developed photophobia. He was hospitalized eight days post-vaccination, and upon admission was noted to be confused and agitated. Physical examination showed a temperature of 38.2 degrees Celsius, increased upper extremity tone, low-frequency tremor, and a Glasgow coma score of 10. A rash was noted at the site of vaccination. Lumbar puncture revealed an opening pressure of 15 cm of water, a protein concentration of 122 mg/dL, and a WBC count of 294 cells/uL, with 76% lymphocytes and 24% neutrophils. An electroencephalogram revealed diffuse theta-frequency slowing without epileptiform discharges; brain MRI showed no significant abnormalities. The patient was initially treated with ACYCLOVIR, and then PHENYTOIN when he developed generalized seizures. A repeat lumbar puncture 11 days post-vaccination showed an opening pressure of 19 cm of water, a protein concentration of 95 mg/dL, and a WBC count of 137 cell/uL, with 89% lymphocytes, 1% neutrophils, and 10% monocytes. His status improved gradually, and he was discharged 16 days post-vaccination. At the time of discharge, he exhibited residual deficits in short-term memory, coordination, and balance. Serum and CSF samples sent to the Poxvirus Program at the CDC were negative for orthopox virus DNA, and IgM antibody was undetectable. Vaccinia-specific IgG antibody was detected in both serum and CSF. Results of extensive testing for infectious agents were negative. According to the authors, "the five-day lapse to onset of neurological symptoms after secondary smallpox vaccination and lack of evidence of direct CNS infection suggest an autoimmune response to vaccination". In conclusion, it was noted that "the patient in this report meets the surveillance case definition for probably PVE(postvaccinia encephalitis)."
Age: 40.0
Sex: M
Vaccine: FLUN3, HEPA, SMALL, TYP
Symptoms: Polymerase chain reaction, Pyrexia, Tremor, Virus serology test positive
Clinical narrative: This serious case was received via a search of the scientific literature on 12 January 2009. A 40-year-old male serviceman received the following vaccinations on an unknown day in 2005 in preparation for active military duty: smallpox vaccine, typhoid vaccine, hepatitis A vaccine, (manufacturers not reported) and FLUMIST (MedImmune Vaccines). Lot numbers, and site of administration were not reported. The patient had received a primary smallpox vaccination in 1986, 19 years earlier, when he joined the military. He had no reported medical history. Five days post-vaccination, the patient developed photophobia. He was hospitalized eight days post-vaccination, and upon admission was noted to be confused and agitated. Physical examination showed a temperature of 38.2 degrees Celsius, increased upper extremity tone, low-frequency tremor, and a Glasgow coma score of 10. A rash was noted at the site of vaccination. Lumbar puncture revealed an opening pressure of 15 cm of water, a protein concentration of 122 mg/dL, and a WBC count of 294 cells/uL, with 76% lymphocytes and 24% neutrophils. An electroencephalogram revealed diffuse theta-frequency slowing without epileptiform discharges; brain MRI showed no significant abnormalities. The patient was initially treated with ACYCLOVIR, and then PHENYTOIN when he developed generalized seizures. A repeat lumbar puncture 11 days post-vaccination showed an opening pressure of 19 cm of water, a protein concentration of 95 mg/dL, and a WBC count of 137 cell/uL, with 89% lymphocytes, 1% neutrophils, and 10% monocytes. His status improved gradually, and he was discharged 16 days post-vaccination. At the time of discharge, he exhibited residual deficits in short-term memory, coordination, and balance. Serum and CSF samples sent to the Poxvirus Program at the CDC were negative for orthopox virus DNA, and IgM antibody was undetectable. Vaccinia-specific IgG antibody was detected in both serum and CSF. Results of extensive testing for infectious agents were negative. According to the authors, "the five-day lapse to onset of neurological symptoms after secondary smallpox vaccination and lack of evidence of direct CNS infection suggest an autoimmune response to vaccination". In conclusion, it was noted that "the patient in this report meets the surveillance case definition for probably PVE(postvaccinia encephalitis)."
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Alpha 1 foetoprotein normal, Ankle fracture, Drug exposure during pregnancy, Ultrasound scan normal
Clinical narrative: Information has been received for the Pregnancy Registry from a nurse concerning a 27 year old female with asthma and allergy to VICODIN with a history of 1 pregnancy a history of a spontaneous abortion who on 29-MAY-2007 was vaccinated IM in the left deltoid with a first dose of with GARDASIL 657622/0388U.  Concomitant therapy included ALLEGRA, ALBUTEROL, vitamins (unspecified), ZYRTEC and "DUET DHA" [therapy unspecified].  On an unspecified date the patient was vaccinated with a second dose of GARDASIL.  On 14-APR-2008 contained the following adverse experience:  Broken ankle (31-OCT-2008).  Patient Concomitant medication included BRETHINE INJECTION.  Maternal Serum Alpha Fetoprotein test was performed on 23-JUN-2008, the results were within normal limits.  The licensed practical nurse reported that on 24-NOV-2008 the patient delivered a normal, healthy male baby, APGAR score 8/9.  This report contained the following adverse event:  Broken ankle (31-OCT-2008).  Patient Concomitant medication included BRETHINE INJECTION.  Maternal Serum Alpha Fetoprotein test was performed on 23-JUN-2008, the results were within normal limits.  The licensed practical nurse reported that on 24-NOV-2008 the patient delivered a normal, healthy male baby, APGAR score 8/9.  This report contained the following adverse event: broken ankle (31-OCT-2008) and the patient was treated with HERAPIN from 31-OCT-2008 until 24-NOV-2008.  This report is related to 0708USA01062.  Additional information is not expected.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Hyperventilation, Vomiting
Clinical narrative: Information has been received from a physician concerning an 18 year old female patient who on 11-DEC-2008 was vaccinated with the second dose of GARDASIL (lot # not provided).  After receiving the dose the patient was left alone to have some privacy in the room, and then someone came to check on her and she had vomited, felt light headed, dizzy and was hyperventilating.  Patient sought unspecified medical attention.  No lab diagnostics
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, HEPA, HPV4
Symptoms: Amenorrhoea, Back pain, Blood test, Computerised tomogram, Ear pain
Clinical narrative: Information has been received from a consumer concerning her 19 year old daughter with no known allergies and no pertinent medical history who on 01-MAY-2008 was vaccinated with 0.5ml of a dose of GARDASIL intramuscularly. Concomitant therapy included hepatitis A virus vaccine (unspecified). Since June 2008, the patient had been experiencing :syncopal episode". She had gone to the ER 6-7 times and was admitted in December. 2008. The reporter also stated that the patient was scheduled to be admitted again in January, 2009. An electrocardiogram, magnetic resonance imaging, computed axial tomography and an Electroencephalography were performed (2008,; no results reported). As of 29-DEC-2008 the patient was not recovered. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, HEPA, HPV4
Symptoms: Headache, Immobile, Loss of consciousness, Menstruation irregular, Migraine
Clinical narrative: Information has been received from a consumer concerning her 19 year old daughter with no known allergies and no pertinent medical history who on 01-MAY-2008 was vaccinated with 0.5ml of a dose of GARDASIL intramuscularly. Concomitant therapy included hepatitis A virus vaccine (unspecified). Since June 2008, the patient had been experiencing :syncopal episode". She had gone to the ER 6-7 times and was admitted in December. 2008. The reporter also stated that the patient was scheduled to be admitted again in January, 2009. An electrocardiogram, magnetic resonance imaging, computed axial tomography and an Electroencephalography were performed (2008,; no results reported). As of 29-DEC-2008 the patient was not recovered. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, HEPA, HPV4
Symptoms: Nausea, Pain in extremity, Paraesthesia, Syncope
Clinical narrative: Information has been received from a consumer concerning her 19 year old daughter with no known allergies and no pertinent medical history who on 01-MAY-2008 was vaccinated with 0.5ml of a dose of GARDASIL intramuscularly. Concomitant therapy included hepatitis A virus vaccine (unspecified). Since June 2008, the patient had been experiencing :syncopal episode". She had gone to the ER 6-7 times and was admitted in December. 2008. The reporter also stated that the patient was scheduled to be admitted again in January, 2009. An electrocardiogram, magnetic resonance imaging, computed axial tomography and an Electroencephalography were performed (2008,; no results reported). As of 29-DEC-2008 the patient was not recovered. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, HEPA, HPV4
Symptoms: Computerised tomogram, Electrocardiogram, Electroencephalogram, Nuclear magnetic resonance imaging, Syncope
Clinical narrative: Information has been received from a consumer concerning her 19 year old daughter with no known allergies and no pertinent medical history who on 01-MAY-2008 was vaccinated with 0.5ml of a dose of GARDASIL intramuscularly. Concomitant therapy included hepatitis A virus vaccine (unspecified). Since June 2008, the patient had been experiencing :syncopal episode". She had gone to the ER 6-7 times and was admitted in December. 2008. The reporter also stated that the patient was scheduled to be admitted again in January, 2009. An electrocardiogram, magnetic resonance imaging, computed axial tomography and an Electroencephalography were performed (2008,; no results reported). As of 29-DEC-2008 the patient was not recovered. Additional information has been requested.
Sex: M
Vaccine: PNC
Symptoms: Autism
Clinical narrative: This case was considered medically important.  Information regarding PREVNAR was received from a consumer regarding a 6-year-old male patient who experienced autism.  The patient received the fourth dose on an unspecified date.  On an unspecified date, the patient experienced autism.  The outcome was unknown.  No additional information was available at the time of this report.
Age: 1.0
Sex: M
Vaccine: FLU3, HEPA, HIBV, MMR, PNC, VARCEL
Symptoms: Death, Dyspnoea, Hypotonia, Unresponsive to stimuli
Clinical narrative: Pt given HIB #4; PREVNAR #4; Hepatitis A #1; MMR #1; Varicella #1 and Influenza #1 on 11-17-08. Pt presented one week later "barely breathing"; flacid and unresponsive to verbal-painful stimuli at 1755-transferred-died at local hospital a couple of hours later.  2/12/09 PCP and hospital records received from FDA.  Pt with mild fever 11/24/08 put down to nap. Ptfound  to be diaphoretic, limp, minimally breathing and non-interactive in crib. Upon arrival of EMS pt noted to be unresponsive to stim, satring with no blink response, pulse 160, RR 32 with rhonchi bilaterally R>L.  Dx with severe croup at local hospital with transport planned to higher level of care. In ER unresponsive in severe respiratory distress, skin mottled, O2 sats 80s-90s on pale toes. Arrived to transfer hospital unresposive to pain, lethargic, initially flaccid then posturing, (+) cervical lymphadenopathy, resp distress with stridor and rhonchi- intubated. Impression-  Respiratory Failure. Cardiac arrest.  CPR unsuccesful.    3/25/09 Autopsy report received with COD: Community Acquired Pneumonia. Manner of Death:  natural.  Final DX: 1) Acute hemorrhage pneumonia, multifocal, community acquired- a) Diffusely firm, edematous and hemorrhagic lungs, bilaterally. b) Histologic exam confirms purulent multifocal pneumonia.   2)  Moderate Cerebral Edema.  3)  Serous Pleural and Peritoneal Effusions.
Age: 0.18
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Abdominal pain, Bowel movement irregularity, Explorative laparotomy, Haematochezia, Occult blood positive
Clinical narrative: Abd. pain, (+) Stool Guaiac, screaming with eating. Difficult to have BM. Intussusception - admitted 1/11/09 after reduction with air enema. (+) recurrence 1/13/09 with repeat air enema reduction, then surgery.  1/21/09-operative report received for DOS 1/15/09-presented with C/O ileocolic intussusception.  Exploratory laparotomy. Findings: ileocolic intussusception secondary to hypertrophied Peyer's patches in terminal ilieum. The intussusception reduced manually. Appendectomy. Resection Meckel diverticulum. 2/2/09-records received for DOS 1/11-1/17/09-DC DX: Inutssusception. Intussusception reduced on 1/11/09 by air contrast enema after bloody, jelly stool. Presented on 1/13/09 with C/O emesis, increased fussiness, abdominal irritation. US showed recurrence of intussusception.  2/2/09-records received for DOS 1/11-1/17/09-DC DX: Inutssusception. Intussusception reduced on 1/11/09 by air contrast enema after bloody, jelly stool. Presented on 1/13/09 with C/O emesis, increased fussiness, abdominal irritation.  This case was reported by a physician via a sales representative and described the occurrence of intussusception in a 4-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). On an unspecified date the subject received 1st dose of ROTARIX (unknown). One month after vaccination with ROTARIX, the subject experienced intussusception. The subject required surgery and the adverse event resolved. The physician considered the event was clinically significant (or requiring intervention). The physician considered the events was possibly related to vaccination with ROTARIX. Follow-up information received on 26 February 2009 indicated that the subject was a 4 month old female. She received oral ROTARIX on 18 November 2008. Almost two months later, on 07 January 2009, symptoms began. A diagnosis of intussusception was made on 10 January 2009. The subject underwent surgical reduction with no resection on 15 January 2009. The event resolved on 17 January 2009. In addition to intervention, this case was considered to be serious as the event was life threatening and the subject was hospitalized. In the physician's opinion, the events were possibly related to treatment with ROTARIX.
Age: 0.18
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Screaming, Surgery, Ultrasound scan abnormal
Clinical narrative: Abd. pain, (+) Stool Guaiac, screaming with eating. Difficult to have BM. Intussusception - admitted 1/11/09 after reduction with air enema. (+) recurrence 1/13/09 with repeat air enema reduction, then surgery.  1/21/09-operative report received for DOS 1/15/09-presented with C/O ileocolic intussusception.  Exploratory laparotomy. Findings: ileocolic intussusception secondary to hypertrophied Peyer's patches in terminal ilieum. The intussusception reduced manually. Appendectomy. Resection Meckel diverticulum. 2/2/09-records received for DOS 1/11-1/17/09-DC DX: Inutssusception. Intussusception reduced on 1/11/09 by air contrast enema after bloody, jelly stool. Presented on 1/13/09 with C/O emesis, increased fussiness, abdominal irritation. US showed recurrence of intussusception.  2/2/09-records received for DOS 1/11-1/17/09-DC DX: Inutssusception. Intussusception reduced on 1/11/09 by air contrast enema after bloody, jelly stool. Presented on 1/13/09 with C/O emesis, increased fussiness, abdominal irritation.  This case was reported by a physician via a sales representative and described the occurrence of intussusception in a 4-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). On an unspecified date the subject received 1st dose of ROTARIX (unknown). One month after vaccination with ROTARIX, the subject experienced intussusception. The subject required surgery and the adverse event resolved. The physician considered the event was clinically significant (or requiring intervention). The physician considered the events was possibly related to vaccination with ROTARIX. Follow-up information received on 26 February 2009 indicated that the subject was a 4 month old female. She received oral ROTARIX on 18 November 2008. Almost two months later, on 07 January 2009, symptoms began. A diagnosis of intussusception was made on 10 January 2009. The subject underwent surgical reduction with no resection on 15 January 2009. The event resolved on 17 January 2009. In addition to intervention, this case was considered to be serious as the event was life threatening and the subject was hospitalized. In the physician's opinion, the events were possibly related to treatment with ROTARIX.
Age: 0.18
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Intussusception, Surgery
Clinical narrative: Abd. pain, (+) Stool Guaiac, screaming with eating. Difficult to have BM. Intussusception - admitted 1/11/09 after reduction with air enema. (+) recurrence 1/13/09 with repeat air enema reduction, then surgery.  1/21/09-operative report received for DOS 1/15/09-presented with C/O ileocolic intussusception.  Exploratory laparotomy. Findings: ileocolic intussusception secondary to hypertrophied Peyer's patches in terminal ilieum. The intussusception reduced manually. Appendectomy. Resection Meckel diverticulum. 2/2/09-records received for DOS 1/11-1/17/09-DC DX: Inutssusception. Intussusception reduced on 1/11/09 by air contrast enema after bloody, jelly stool. Presented on 1/13/09 with C/O emesis, increased fussiness, abdominal irritation. US showed recurrence of intussusception.  2/2/09-records received for DOS 1/11-1/17/09-DC DX: Inutssusception. Intussusception reduced on 1/11/09 by air contrast enema after bloody, jelly stool. Presented on 1/13/09 with C/O emesis, increased fussiness, abdominal irritation.  This case was reported by a physician via a sales representative and described the occurrence of intussusception in a 4-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). On an unspecified date the subject received 1st dose of ROTARIX (unknown). One month after vaccination with ROTARIX, the subject experienced intussusception. The subject required surgery and the adverse event resolved. The physician considered the event was clinically significant (or requiring intervention). The physician considered the events was possibly related to vaccination with ROTARIX. Follow-up information received on 26 February 2009 indicated that the subject was a 4 month old female. She received oral ROTARIX on 18 November 2008. Almost two months later, on 07 January 2009, symptoms began. A diagnosis of intussusception was made on 10 January 2009. The subject underwent surgical reduction with no resection on 15 January 2009. The event resolved on 17 January 2009. In addition to intervention, this case was considered to be serious as the event was life threatening and the subject was hospitalized. In the physician's opinion, the events were possibly related to treatment with ROTARIX.
Age: 0.37
Sex: M
Vaccine: FLU3, HEPA
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: 4 month old male, received shots by mistake; Hep A (HAV) and FLUZONE. No adverse reaction occurred.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Abdominal pain upper, Eyelid oedema
Clinical narrative: Mother states "eye lids swelling, and severe stomach cramps". Was not seen by physician in office after symptoms occurred.
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Rash
Clinical narrative: Presented to office on 1/9/09 c/o "rash".  10 days post vaccination hospital + eruption consistent with H. ZOSTER RT TIV Denmatine treated with ACYCLOVIR 800 mg.
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster
Clinical narrative: Presented to office on 1/9/09 c/o "rash".  10 days post vaccination hospital + eruption consistent with H. ZOSTER RT TIV Denmatine treated with ACYCLOVIR 800 mg.
Age: 1.9
Sex: M
Vaccine: DTAP, HEP, IPV, MMR, PNC, VARCEL
Symptoms: Febrile convulsion, Tremor
Clinical narrative: ? febrile sz on 1/16/09 - started seizuring, eyes open wide, then shaking all over, then fell asleep for approximately 1 hr.  Had 2nd febrile episode shortly after that.
Age: 0.9
Sex: M
Vaccine: DTAP, FLU3, HIBV, IPV, PNC
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Irritability, Pyrexia
Clinical narrative: Localized redness, lump, tenderness at right thigh. Fever 99-102.6. Vomiting x 1 on 1/14/09. Irritable and cranky. Treated with TYLENOL-MOTRIN. Symptoms started 1/14/09.
Age: 0.9
Sex: M
Vaccine: DTAP, FLU3, HIBV, IPV, PNC
Symptoms: Vomiting
Clinical narrative: Localized redness, lump, tenderness at right thigh. Fever 99-102.6. Vomiting x 1 on 1/14/09. Irritable and cranky. Treated with TYLENOL-MOTRIN. Symptoms started 1/14/09.
Age: 80.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injected limb mobility decreased, Injection site pain, Myalgia, Pain in extremity, Sleep disorder
Clinical narrative: Pt complained of pain in muscle around site of injection within days of receiving vaccine.  The pain has radiated up and down arm, has affected sleep and range of motion.  Has been under physician care for this problem.
Age: 80.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Pain in extremity
Clinical narrative: Pt complained of pain in muscle around site of injection within days of receiving vaccine.  The pain has radiated up and down arm, has affected sleep and range of motion.  Has been under physician care for this problem.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Muscular weakness, Nuclear magnetic resonance imaging, Pain in extremity
Clinical narrative: 1st attempt to administer dose: Unable to get plunger down (resistance) so gave 1/2 dose same arm similar area and was able to give dose. Pt stated her arm hurts for 2 months after Flu shot and usually pain resolved but not with this dose. Arm weak and painful.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Lymphadenopathy, Neutrophil count decreased, Red blood cell sedimentation rate increased
Clinical narrative: Lymph Node swelling
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, VARCEL
Symptoms: Erythema, Immediate post-injection reaction, Skin discolouration, Urticaria
Clinical narrative: red wheel apprx 3" immediately after receiving V2V- wheel baded after 24 hrs after 24 hrs - 3 days after a red/blue discoloration.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, VARCEL
Symptoms: Erythema, Immediate post-injection reaction, Skin discolouration, Urticaria
Clinical narrative: Red wheal immediately after giving V2V 31/2"x4" - Wheal faded after 24 hrs- 3 days later and red/blue discoloration remains.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Ocular hyperaemia
Clinical narrative: Red disc at eye of 50 cent piece pink for at 5-6" from there.
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Computerised tomogram normal, Hyperaesthesia, Pain in extremity
Clinical narrative: Within a few hours after immunization with influenza in the left arm the patient started to experience pain to the slightest touch in the left arm between the deltoid to the elbow.  Mostly localized around the triceps muscle.  Has continued to experience extreme sensitivity to touch over the area with extreme pain.  No swelling or other evidence of inflammation during the course of the symptoms.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Headache, Nausea
Clinical narrative: Headache in "forehead". Nausea - no vomiting.  Onset 01/05/09
Age: 18.0
Sex: F
Vaccine: TDAP
Symptoms: Dizziness, Injection site erythema, Injection site irritation, Injection site swelling
Clinical narrative: Tdap administered R deltoid 1/16/08. Pt describes site becoming swollen & red up to 4 cm circumference with a burning sensation.  She felt dizzy & went to bed. Denies having respiratory or cardiac symptoms. Over the next few days the site decreased in size & she presented today to report her symptoms.  The size of the swelling & redness around the injection site was now 15cm circumference with no pain or burning or other worrisome symptoms.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Activities of daily living impaired, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: After 24 hours, injection site swelled, reddened, itched, hot to touch and was extremely sore in area covering 6 inches by 6 inches.  Pharmacist recommended benadryl. Could not stand to use arm because of swelling and pain.  Five days post injection, the redness has almost disappeared, but the itching and soreness and slight swelling still remain.  Was told by pharmacist this was not abnormal but was unusual.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site warmth
Clinical narrative: After 24 hours, injection site swelled, reddened, itched, hot to touch and was extremely sore in area covering 6 inches by 6 inches.  Pharmacist recommended benadryl. Could not stand to use arm because of swelling and pain.  Five days post injection, the redness has almost disappeared, but the itching and soreness and slight swelling still remain.  Was told by pharmacist this was not abnormal but was unusual.
Age: 20.0
Sex: F
Vaccine: FLU3, HEPA
Symptoms: Drug exposure during pregnancy
Clinical narrative: Client given dose of adult hep A. Client was 2 - 3 mos pregnant at time dose given. Client has not reported an adverse reaction.
Age: 64.0
Sex: M
Vaccine: FLU3
Symptoms: Cough, Dysphagia, Swelling
Clinical narrative: PATIENT CAME INTO OFFICE ON 10-11-2008 DESCRIBING COMPLAINT OF COUGH, SLIGHT SWELLING AND DIFFICULTY SWALLOWING AFTER RECEIVING FLU SHOT ON 10-10-2008.  THE SYMPTOMS STARTED WITHIN A FEW HOURS OF RECEIVING HIS FLU SHOT. PATIENT STATES HE TOOK AN OVER-THE-COUNTER ANTIHISTAMINE AND REPORTS FEELING BETTER AT APPT ON 10-11-08.
Age: 1.58
Sex: M
Vaccine: DTAP, HEPA, IPV, PNC
Symptoms: Abnormal behaviour, Asocial behaviour, Communication disorder, Decreased eye contact, Electroencephalogram abnormal
Clinical narrative: behavioral changes, encephalopathy, change in eye contact, speech delays, social regression 3/17/09-records received-evaluation 8/31/07-Impression-normal visual motor problem solving skills and gross motor skills, mild delay in receptive and expressive language, does not have good eye contact and is not socially interactive. Pervasive Developmental Disorder. Encephalopathy unspecified. Developmental problem noted at about 22 molnths does not turn to his name. Visit on 3/3/08-improvements noted MRI brain not performed. 6/2/08-possible seizures. Staring spells and eye clinching.  Fever-24 hours after vaccine no longer responding to name. No longer communicating with others, regression of social and verbal behaviors.
Age: 1.58
Sex: M
Vaccine: DTAP, HEPA, IPV, PNC
Symptoms: Encephalopathy, Gaze palsy, Mixed receptive-expressive language disorder, Pyrexia, Regressive behaviour
Clinical narrative: behavioral changes, encephalopathy, change in eye contact, speech delays, social regression 3/17/09-records received-evaluation 8/31/07-Impression-normal visual motor problem solving skills and gross motor skills, mild delay in receptive and expressive language, does not have good eye contact and is not socially interactive. Pervasive Developmental Disorder. Encephalopathy unspecified. Developmental problem noted at about 22 molnths does not turn to his name. Visit on 3/3/08-improvements noted MRI brain not performed. 6/2/08-possible seizures. Staring spells and eye clinching.  Fever-24 hours after vaccine no longer responding to name. No longer communicating with others, regression of social and verbal behaviors.
Age: 1.58
Sex: M
Vaccine: DTAP, HEPA, IPV, PNC
Symptoms: Speech disorder developmental, Unresponsive to stimuli
Clinical narrative: behavioral changes, encephalopathy, change in eye contact, speech delays, social regression 3/17/09-records received-evaluation 8/31/07-Impression-normal visual motor problem solving skills and gross motor skills, mild delay in receptive and expressive language, does not have good eye contact and is not socially interactive. Pervasive Developmental Disorder. Encephalopathy unspecified. Developmental problem noted at about 22 molnths does not turn to his name. Visit on 3/3/08-improvements noted MRI brain not performed. 6/2/08-possible seizures. Staring spells and eye clinching.  Fever-24 hours after vaccine no longer responding to name. No longer communicating with others, regression of social and verbal behaviors.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL, HPV4, MNQ, TDAP, VARCEL, HPV4, HPV4, MNQ, TDAP, VARCEL
Symptoms: Balance disorder, Blood test normal, Computerised tomogram normal, Dizziness, Syncope
Clinical narrative: I believe the symptoms started after the second dose. Patient has been having fainting spells where she gets dizzy and sees black with white spots and she loses her balance. It only lasts a few seconds. It has happened at least 25 times or more.  2/23/09 PCP rec received for OV 12/15/08 with c/o black-out episodes  x several months. Sees "spots" then blacks out. Reported loses vision x 4-5 seconds with slow return. PE WNL. Sent for labs and testing.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL, HPV4, MNQ, TDAP, VARCEL, HPV4, HPV4, MNQ, TDAP, VARCEL
Symptoms: Ultrasound scan normal, Visual impairment
Clinical narrative: I believe the symptoms started after the second dose. Patient has been having fainting spells where she gets dizzy and sees black with white spots and she loses her balance. It only lasts a few seconds. It has happened at least 25 times or more.  2/23/09 PCP rec received for OV 12/15/08 with c/o black-out episodes  x several months. Sees "spots" then blacks out. Reported loses vision x 4-5 seconds with slow return. PE WNL. Sent for labs and testing.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL, HPV4, MNQ, TDAP, VARCEL, HPV4, HPV4, MNQ, TDAP, VARCEL
Symptoms: Dizziness, Syncope
Clinical narrative: I believe the symptoms started after the second dose. Patient has been having fainting spells where she gets dizzy and sees black with white spots and she loses her balance. It only lasts a few seconds. It has happened at least 25 times or more.  2/23/09 PCP rec received for OV 12/15/08 with c/o black-out episodes  x several months. Sees "spots" then blacks out. Reported loses vision x 4-5 seconds with slow return. PE WNL. Sent for labs and testing.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL, HPV4, MNQ, TDAP, VARCEL, HPV4, HPV4, MNQ, TDAP, VARCEL
Symptoms: Asthenia, Syncope
Clinical narrative: I believe the symptoms started after the second dose. Patient has been having fainting spells where she gets dizzy and sees black with white spots and she loses her balance. It only lasts a few seconds. It has happened at least 25 times or more.  2/23/09 PCP rec received for OV 12/15/08 with c/o black-out episodes  x several months. Sees "spots" then blacks out. Reported loses vision x 4-5 seconds with slow return. PE WNL. Sent for labs and testing.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL, HPV4, MNQ, TDAP, VARCEL, HPV4, HPV4, MNQ, TDAP, VARCEL
Symptoms: Asthenia, Dizziness, Inappropriate schedule of drug administration, Syncope
Clinical narrative: I believe the symptoms started after the second dose. Patient has been having fainting spells where she gets dizzy and sees black with white spots and she loses her balance. It only lasts a few seconds. It has happened at least 25 times or more.  2/23/09 PCP rec received for OV 12/15/08 with c/o black-out episodes  x several months. Sees "spots" then blacks out. Reported loses vision x 4-5 seconds with slow return. PE WNL. Sent for labs and testing.
Age: 23.0
Sex: F
Vaccine: DTAP
Symptoms: Dizziness, Dyspnoea, Hyperaesthesia, Injection site pain, Myalgia
Clinical narrative: Tues - Administered vaccine Wed - Soreness turning into acute muscle pain around injection site and spreading through back and torso. Thur - breathing difficulty, rash appeared, severe pain throughout body, extreme skin sensitivity, elevated heart rate, nausea, dizziness.  Medical Records and Discharge Summary received 10/12/09.  Date of Admission:9/16/09-9/29/09.  Primary Diagnoses:  Anaphylactic shock secondary to flu shot.  Acute respiratory failure secondary to shock on admission.  Hypokalemia.  Hypomagnesemia.  Acute renal failure. Dehydration.  Malnutrition. Anemia. Assessment:  Patient was admitted to ED 30 minutes after receiving a flu shot c/o abdominal and back pain 9/10, and nausea.  In the ED she was found to be hypotensive and required triple pressors.  BP 84/48, systolics in the 60's, 70's, 80's. Her temperature was 92.7.  Patient was somewhat somnolent, but responsive to verbal commands.  Admitted to the ICU for stabilization.  Patient was transfused 2 units of packed red blood cells.  The patient went into respiratory failure requiring ventilator support secondary to shock. While on the ventilator, the patient was sedated. Pt. noted to be weak and hypocalcemic, she was given 1 gram of calcium IV, hypomagnesemia also present as well as thrombocytopenia.  She had severe metabolic lactic acidosis and profound acidemia and was on a bicarb drip being hyperventilated.  As BP normalized, she was weaned off two pressors.  Urinary output was decreased, but improved.  A central venous line was placed. Noted to have moderate cardiomegaly.  Pulmonary critical care, cardiology and nephrology consults were obtained.  In the ICU patient received supportive care including vent support, pressors and electrolytes as well as IV antibiotics.  As her condition stabilized, the patient was extubated, was doing much better and became stable.  Patient was discharged to a skilled nursing facility for further care.
Age: 23.0
Sex: F
Vaccine: DTAP
Symptoms: Nausea, Rash, Tenderness
Clinical narrative: Tues - Administered vaccine Wed - Soreness turning into acute muscle pain around injection site and spreading through back and torso. Thur - breathing difficulty, rash appeared, severe pain throughout body, extreme skin sensitivity, elevated heart rate, nausea, dizziness.  Medical Records and Discharge Summary received 10/12/09.  Date of Admission:9/16/09-9/29/09.  Primary Diagnoses:  Anaphylactic shock secondary to flu shot.  Acute respiratory failure secondary to shock on admission.  Hypokalemia.  Hypomagnesemia.  Acute renal failure. Dehydration.  Malnutrition. Anemia. Assessment:  Patient was admitted to ED 30 minutes after receiving a flu shot c/o abdominal and back pain 9/10, and nausea.  In the ED she was found to be hypotensive and required triple pressors.  BP 84/48, systolics in the 60's, 70's, 80's. Her temperature was 92.7.  Patient was somewhat somnolent, but responsive to verbal commands.  Admitted to the ICU for stabilization.  Patient was transfused 2 units of packed red blood cells.  The patient went into respiratory failure requiring ventilator support secondary to shock. While on the ventilator, the patient was sedated. Pt. noted to be weak and hypocalcemic, she was given 1 gram of calcium IV, hypomagnesemia also present as well as thrombocytopenia.  She had severe metabolic lactic acidosis and profound acidemia and was on a bicarb drip being hyperventilated.  As BP normalized, she was weaned off two pressors.  Urinary output was decreased, but improved.  A central venous line was placed. Noted to have moderate cardiomegaly.  Pulmonary critical care, cardiology and nephrology consults were obtained.  In the ICU patient received supportive care including vent support, pressors and electrolytes as well as IV antibiotics.  As her condition stabilized, the patient was extubated, was doing much better and became stable.  Patient was discharged to a skilled nursing facility for further care.
Age: 25.0
Sex: M
Vaccine: TYP
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Patient complains of excessive swelling and redness at injectio site, site all is hardened and feels hot to the touch.
Age: 23.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Patient came in on Friday 16 Jan 2009 complaining of excessive swelling at site of injection, redness, hardness, and hot to the touch.
Age: 21.0
Sex: M
Vaccine: ANTH, TYP
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Patient came in complaining of excessive swelling, redness, hardness, and hot at site of injection.
Age: 20.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site erythema, Injection site induration, Injection site mass
Clinical narrative: Patient complains of lump, hardness, and redness at injection site.
Age: 23.0
Sex: M
Vaccine: ANTH
Symptoms: Pyrexia
Clinical narrative: Patient complaining of fever.
Age: 1.08
Sex: M
Vaccine: VARCEL
Symptoms: Pruritus, Rash maculo-papular
Clinical narrative: PT DEVELOPED MACULOPAPULAR RASH 1/19 ON FACE THAT SPREAD TO TRUNK AND ARMS AND LEGS TODAY.  ITCHY.
Age: 47.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site urticaria
Clinical narrative: PATIENT RECIEVED VACCINATION ON 01/15/09. HAD RED WELT AT INJECTION SITE APPROXIMATELY 3 INCHES IN DIAMETER WITHIN 24 HOURS. WELT PROGRESSED TO 6 INCHES IN DIAMETER OVER THE NEXT 48 HOURS, THEN REDUCED TO A SMALL WELT AT THE TIME OF CALL TO ADMINISTRATOR ON 01/20/09.
Age: 1.25
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Skin warm, Swelling face
Clinical narrative: Cheeks swollen and hot
Age: 5.0
Sex: F
Vaccine: HEPA
Symptoms: Urticaria
Clinical narrative: PATIENT STARTIED TO BREAK OUT IN HIVES ON FACE & CHEST UPON ARRIVAL AT HOME APPROX 30 MINS AFTER VACCINE. NO COUGH/WHEEZE/RESPIRATORY DISTREES/ FACILA EDMA. MOTHER ADMINISTERED BENADRYL ORALLY. HIVES RESOLVED WITHIN 45 MINS. PATIENT IS ALLERGIC TO SOY/PEANUTS
Sex: M
Vaccine: MNQ, TDAP, UNK
Symptoms: Injection site erythema, Injection site urticaria, Pruritus, Rash erythematous, Rash pruritic
Clinical narrative: PT HAD LOCALIZED HIVE REACTION AT THE PPD SITE IN 24HOURS. BY 36HRS DEVELOPED ITCHY RED BUMPS WITH HALO & SOME HIVES ON TRUNK, ARMS, & LEGS. HAD BEEN TREATING W/ BENADRYL BUT ONCE WHOLE BODY REACTION WE GAVE BENADRYL, SINGULAIR, PEPCID & STEROID TAPER. NO ITCHING & ONLY MILD ERYTHEMA @ SITE OF OTHER VACCINES SO DO NOT THINK  IT WAS THE VACCINES. PPD SITE RAISED/PRUITIC ON THE SAME ARM WHERE HIVE REACTION STARTED.
Sex: M
Vaccine: MNQ, TDAP, UNK
Symptoms: Urticaria
Clinical narrative: PT HAD LOCALIZED HIVE REACTION AT THE PPD SITE IN 24HOURS. BY 36HRS DEVELOPED ITCHY RED BUMPS WITH HALO & SOME HIVES ON TRUNK, ARMS, & LEGS. HAD BEEN TREATING W/ BENADRYL BUT ONCE WHOLE BODY REACTION WE GAVE BENADRYL, SINGULAIR, PEPCID & STEROID TAPER. NO ITCHING & ONLY MILD ERYTHEMA @ SITE OF OTHER VACCINES SO DO NOT THINK  IT WAS THE VACCINES. PPD SITE RAISED/PRUITIC ON THE SAME ARM WHERE HIVE REACTION STARTED.
Age: 0.89
Sex: F
Vaccine: DTAPHEPBIP, HEP, HIBV, PNC, RV5
Symptoms: Abdominal pain upper, Chest X-ray, Condition aggravated, Cough, Dysphonia
Clinical narrative: I have seen the slightest symptoms since the begining of her chart. Constant sinus infections accompained by a wheeze and cough. She also is having some various allergies to food. There was some dental abnormalities no enamel over the teeth. I noticed some headaches with a little hoarseness. I have also been concerned that her reflex system seems slower. Stomach aches?  2/5/09 Received PCP medical records of 4/7/2009-1/15/2009. FINAL DX: Records reveal patient in foster care & experienced frequent URIs & dx w/probable asthma w/nocturnal cough & wheezing.  12/13/08 had RSV bronchiolitis, exacerbation of asthma & OM.
Age: 0.89
Sex: F
Vaccine: DTAPHEPBIP, HEP, HIBV, PNC, RV5
Symptoms: Headache, Hyporeflexia, Sinusitis, Wheezing
Clinical narrative: I have seen the slightest symptoms since the begining of her chart. Constant sinus infections accompained by a wheeze and cough. She also is having some various allergies to food. There was some dental abnormalities no enamel over the teeth. I noticed some headaches with a little hoarseness. I have also been concerned that her reflex system seems slower. Stomach aches?  2/5/09 Received PCP medical records of 4/7/2009-1/15/2009. FINAL DX: Records reveal patient in foster care & experienced frequent URIs & dx w/probable asthma w/nocturnal cough & wheezing.  12/13/08 had RSV bronchiolitis, exacerbation of asthma & OM.
Age: 47.0
Sex: M
Vaccine: FLUX
Symptoms: Activities of daily living impaired, Dizziness, Headache, Heart rate increased, Influenza like illness
Clinical narrative: A week after I received my flu shot I fell ill with a severe flu?/viral infection? that took me six weeks to recover from. Symptoms: On the first day, severe dizziness (could not get out of bed), strong headache, nausea, low-grade fever, fast pulse, restlessness. Dizziness better after first day. Low-grade fever continued for a week. Outbreak of flu?/viral infection? may or may not be connected to flu-shot. At the time I took the flu shot I did not show any symptoms of being unwell. I have been having a flu shot for over ten years and have never shown a reaction. PS: I don't know the name of the vaccine manufacturer health center used.
Age: 47.0
Sex: M
Vaccine: FLUX
Symptoms: Nausea, No reaction on previous exposure to drug, Pyrexia, Restlessness
Clinical narrative: A week after I received my flu shot I fell ill with a severe flu?/viral infection? that took me six weeks to recover from. Symptoms: On the first day, severe dizziness (could not get out of bed), strong headache, nausea, low-grade fever, fast pulse, restlessness. Dizziness better after first day. Low-grade fever continued for a week. Outbreak of flu?/viral infection? may or may not be connected to flu-shot. At the time I took the flu shot I did not show any symptoms of being unwell. I have been having a flu shot for over ten years and have never shown a reaction. PS: I don't know the name of the vaccine manufacturer health center used.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Vaccination complication, Varicella zoster serology negative, Varicella zoster virus serology positive
Clinical narrative: Patient received 2 varicella vaccines (2/23/05, 1/28/08). Patient presented to the office on 1/14/09 with scattered pox-lke lesions.  Varicella titer obtained on that date.  Results were IgG 2.49, IgM <0.91.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, VARCEL
Symptoms: Contusion, Urticaria
Clinical narrative: 6:45pm Jan 17th mom noticed welts & bruising on child's side.  She took her to the ER.  Seen by MD + welts & bruising spread down body to ankles, transported by ambulance to center.  Released 1-20-09.  1/27/09 Received hospital medical records of 1/19-1/20/2009. FINAL DX: no d/c summary available.  Allergy consult states: purpura, mild leukocytosis Records reveal patient experienced petechial maculopapular purpura rash & swelling of RLE w/right /ankle/foot arthralgia.  Taken to outlying ER where rash & swelling noted of bilateral LEs. Allergy consult done.  .
Age: 2.0
Sex: M
Vaccine: DTAP, HIBV, IPV, MMR
Symptoms: Autism, Brain injury, Computerised tomogram, Epilepsy, Grand mal convulsion
Clinical narrative: Severe seizure (grand mal) lasting over 3 hours. Life flighted and hospitalized for 5 days. Results-permanent brain damage to the left hippocampus.Since his vaccination, he has epilepsy, autism, sensory processing disorder and brain damage. He will be having brain surgery on 3/15/2010.
Age: 2.0
Sex: M
Vaccine: DTAP, HIBV, IPV, MMR
Symptoms: Lumbar puncture abnormal, Nuclear magnetic resonance imaging, Sensory integrative dysfunction
Clinical narrative: Severe seizure (grand mal) lasting over 3 hours. Life flighted and hospitalized for 5 days. Results-permanent brain damage to the left hippocampus.Since his vaccination, he has epilepsy, autism, sensory processing disorder and brain damage. He will be having brain surgery on 3/15/2010.
Age: 15.0
Sex: M
Vaccine: FLU3, HEPA
Symptoms: Computerised tomogram normal, Convulsion, Scan brain
Clinical narrative: Seizures X 2 1-5-09.  First time seizures.  1/23/09 Reviewed hospital medical records of 1/5-1/6/2009. FINAL DX: new onset seizures Records reveal patient experienced tingling in feet, stiffening movements while at school & had generalized convulsion, apnea, jaw clenching, loss of consciousness & postictal behavior.  Had witnessed seizure in ER.  Neuro consult done.  Tx w/meds & no further seizures while hospitalized.  D/C to home on continued oral meds.
Age: 41.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Antinuclear antibody, Burning sensation, Chest X-ray, Full blood count, Headache
Clinical narrative: Pt had TDAP vaccine on 10/29/08, exhibited expected s/sx after injection "knot at side, pain, fever, headache". Two weeks later had lymph node on clavicle. Having periodic pain (burning) to arm, top of shoulder and clavicle area - having ODS to remove lymph node.